Edwards Larry Todd
Chief Commercial Officer
Edwards Larry Todd has filed 5 SEC Form 4 filings (8 transaction rows) across 2 companies, including ORKA, ARQT, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Aug 25, 2026.
On the most recent filing, Edwards Larry Todd is listed as See Remarks at Arcutis Biotherapeutics, Inc. Inside the rolling window, Edwards Larry Todd reported no open-market purchases and 3 open-market sales totaling $878K in ARQT. The largest disclosed transaction in the window is a sale of 29,131 ARQT shares on Nov 6, 2025, worth $733K.
Companies traded
Other insiders at ORKA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$878K
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Edwards Larry Todd made?
Edwards Larry Todd has filed 5 SEC Form 4 filings (8 transaction rows) across 2 companies, including ORKA, ARQT since 2025.
Which companies does Edwards Larry Todd trade?
Edwards Larry Todd has filed SEC Form 4 disclosures for 2 companies, including ORKA, ARQT.
When was Edwards Larry Todd's most recent SEC Form 4 filing?
Edwards Larry Todd's most recent SEC Form 4 filing on Tracefour is dated Aug 25, 2026.
What is Edwards Larry Todd's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Edwards Larry Todd is listed as Chief Commercial Officer.
What is Edwards Larry Todd's total buy and sell value in the current window?
Inside the rolling retention window, Edwards Larry Todd bought $0 and sold $878K based on SEC Form 4 filings.
What was Edwards Larry Todd's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 29,131 ARQT shares on 2025-11-06, worth $733K, per SEC Form 4 filings.